Holen Sie sich die Stockscreener-App
271.35
1.57%
-4.32
Handel nachbörslich:
272.00
0.65
+0.24%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$275.67
Offen:
$275
24-Stunden-Volumen:
1.85M
Relative Volume:
0.82
Marktkapitalisierung:
$32.67B
Einnahmen:
$115.01B
Nettoeinkommen (Verlust:
$1.36B
KGV:
11.25
EPS:
24.12
Netto-Cashflow:
$-4.34B
1W Leistung:
-3.93%
1M Leistung:
+1.58%
6M Leistung:
-23.82%
1J Leistung:
-45.52%
1-Tages-Spanne:
$270.81
$279.43
1-Wochen-Bereich:
$270.81
$291.09
52-Wochen-Spanne:
$213.31
$527.18
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
500 W MAIN ST, LOUISVILLE, KY
Vergleichen Sie HUM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| HUM | 271.35 | 32.67B | 115.01B | 1.36B | -4.34B | 24.12 |
| UNH | 589.65 | 544.99B | 389.07B | 14.32B | 13.10B | 23.04 |
| ELV | 400.70 | 92.77B | 174.02B | 6.42B | 871.00M | 25.47 |
| CI | 322.45 | 89.32B | 229.75B | 3.04B | 5.18B | 17.73 |
| CVS | 56.05 | 70.53B | 368.91B | 5.02B | 1.69B | 6.63 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Mawer Investment Management Ltd. Lowers Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (NYSE:HUM) Stock Holdings Raised by Empowered Funds LLC - MarketBeat
S&CO Inc. Increases Position in Humana Inc. (NYSE:HUM) - MarketBeat
Kinsale Capital Group Inc. Increases Stake in Humana Inc. (NYSE:HUM) - MarketBeat
KBC Group NV Sells 10,347 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Victory Capital Management Inc. Trims Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (NYSE:HUM) Sees Significant Increase in Short Interest - MarketBeat
Mizuho Securities USA LLC Buys 84,897 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (NYSE:HUM) Receives $315.86 Average PT from Analysts - MarketBeat
Humana Inc. stock underperforms Friday when compared to competitors - MarketWatch
Humana and Evolent expand partnership to enhance oncology care - The Cancer Letter
FY2024 Earnings Estimate for Humana Issued By Zacks Research - MarketBeat
Investors in Humana (NYSE:HUM) have unfortunately lost 44% over the last year - Yahoo Finance
Humana Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Sivik Global Healthcare LLC Boosts Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
Do You Believe in Humana Inc. (HUM)’s Long-Term Strength? - Insider Monkey
Several Headwinds Dragged Humana (HUM) in Q3 - MSN
Sumitomo Mitsui Trust Group Inc. Increases Stock Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana adds to C-suite - Louisville Business First
Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors - The Manila Times
Tarsus Pharma Strengthens Board with Humana CMO Dr. Kate Goodrich Appointment | TARS Stock News - StockTitan
Assetmark Inc. Grows Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Stock Slumps as Cigna Says It's Not Pursuing Combination - MSN
Community Health sues Humana to recover $7.3M in payments for drugs to low-income and uninsured - Inside INdiana Business
Humana Inc. stock outperforms competitors despite losses on the day - MarketWatch
Humana Medicare Advantage Review 2024 - Forbes
Humana Appoints Michelle O'Hara as Chief Human Resources Officer - Business Wire
Insurance plans evaluation leads to termination of Humana, Aetna MAs at MyMichigan Health - Iosco County News Herald
Cigna ends merger talks with Humana - Business Insurance
Cigna denies speculation of a Humana deal - Health & Protection
Cigna Ends Humana Merger Speculation: CI Jumps 7.3% While HUM Slips - Yahoo Finance
GSA Capital Partners LLP Has $2.89 Million Stock Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
Entropy Technologies LP Acquires Shares of 14,767 Humana Inc. (NYSE:HUM) - MarketBeat
Cigna drops Humana merger talksLouisville Business First - The Business Journals
Best Insurance Companies for Medicare Advantage in 2025 - U.S. News & World Report
Cigna says they are no longer pursuing merger with Humana - WHAS11.com
Humana Recognized for Commitment to Veteran Employment by Military Times and Military Friendly - Business Wire
Why Cigna Stock Popped Today - The Motley Fool
Why Cigna Deal With Humana Made Little Sense To Begin With - Forbes
Humana (NYSE:HUM) Shares Gap DownHere's What Happened - MarketBeat
Cigna-Humana fallout, Trump 2.0 impact: Catalysts - Yahoo Finance UK
Cigna confirms it won’t pursue combination with rival Humana - Indianapolis Business Journal
Cigna says it is not pursuing deal with rival Humana, shares rise - Reuters
Cigna nixes speculation of a Humana merger - Healthcare Finance News
Cigna Crushes Humana Merger Hopes, Sends Stock Soaring Nearly 8% - Yahoo Finance UK
Cigna confirms it is not pursuing Humana acquisition - BioPharma Dive
Cigna officially confirms it's not pursuing a Humana acquisition - Fierce healthcare
Cigna ends Humana merger talks, prioritizes share buybacks - Modern Healthcare
Cigna Confirms It Won’t Pursue Combination With Rival Humana - Yahoo Finance
Cigna rallies after Humana mega-merger called off - Proactive Investors USA
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.38%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):